Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

1120 of over 10 results
Interim Immunization Protocol (RSV)
2025 · Oregon Health Authority
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant …
Childhood Vaccines: What Immunizations Are Recommended and At What Age?
2025 · NewYork-Presbyterian
This article explains the importance of childhood vaccines and following the recommended immunization schedule. Dr. Melissa Stockwell, a pediatric expert, assures that vaccines are safe …
Making Vaccine Decisions During Pregnancy: What to Know
2025 · Children's Hospital of Philadelphia
This newsletter describes the importance of four vaccines during pregnancy: influenza, COVID-19, Tdap, and RSV. These vaccines protect both mothers and babies from severe diseases. …
Should You Get an RSV Vaccine?
2025 · Yale University
This news article describes the importance of getting an RSV vaccine, especially for older adults and babies. RSV is a virus that can cause serious …
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates
2025 · University of California San Francisco
This study was conducted to describe the uptake of the prenatal RSVpreF vaccine and infant nirsevimab during the 2023-2024 RSV season. It found high uptake …
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season
2025 · Beth Israel Deaconess Medical Center, · Harvard Medical School
This research letter looks at a study that analyzed the uptake of RSVpreF vaccination during pregnancy and nirsevimab administration to infants during the 2023 to …
Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024
2025 · Kaiser Permanente
The article investigates the uptake of maternal RSV vaccination and infant nirsevimab among infants born from October 2023 to March 2024 within Kaiser Permanente Northern …
Improving Palivizumab Administration to High-Risk Infants with Heart Disease via a Communication-Based Quality Improvement Initiative
2025 · Yale University, · Yale New Haven Health System
This article describes a project to improve the administration of palivizumab, a medication for high-risk infants with heart disease. A team at Yale University worked …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
1120 of over 10 results